As of Dec 09
| +0.30 / +2.78%|
The 7 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 24.00, with a high estimate of 28.00 and a low estimate of 15.00. The median estimate represents a +116.22% increase from the last price of 11.10.
The current consensus among 8 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.